Skip to content

Mississippi Medicaid

Does Mississippi Medicaid cover Mounjaro for Type 2 Diabetes?

Yes. Mississippi Medicaid covers Mounjaro for type 2 diabetes with prior authorization. Other policy requirements and your plan's benefits also apply.

Policy document

  • Medicaid: Covered with requirements. See the qualification pathways below.

Earliest policy review June 4, 2026. How we verify · Check your exact plan · Medicaid card names in Mississippi

Full requirements: Mounjaro for Type 2 Diabetes (1 plan type)

Applies to Medicaid plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Non-Preferred: Step therapy from preferred agents with T2DM diagnosis

All of:

  • Documented diagnosis of Type 2 Diabetes
  • No history of Saxenda or Wegovy in the past 30 days
  • 84 days of therapy with Trulicity in the past 6 months
  • 84 days of therapy with either preferred Byetta or Victoza in the past 6 months

Non-Preferred: Continuity of care with T2DM diagnosis

All of:

  • Documented diagnosis of Type 2 Diabetes
  • 84 days of therapy with the requested agent in the past 105 days

Documentation to bring

  • Documented diagnosis of Type 2 Diabetes
  • Documentation of no Saxenda or Wegovy use in the past 30 days (for step-therapy pathway)
  • Documentation of 84 days of Trulicity therapy in the past 6 months (for step-therapy pathway)
  • Documentation of 84 days of therapy with Byetta or Victoza in the past 6 months (for step-therapy pathway)
  • Documentation of 84 days of therapy with the requested agent in the past 105 days (for continuity pathway)

Not covered when

  • History of Saxenda or Wegovy in the past 30 days (for step-therapy pathway)
  • Concomitant use of a GLP-1 agonist and a DPP-4 agent requires clinical review

Policy note: Mounjaro is listed as a non-preferred agent. Two distinct non-preferred qualification pathways exist: (1) step therapy through Trulicity + Byetta or Victoza for T2DM patients without recent Saxenda/Wegovy use, or (2) continuity of care (84 days of the requested agent in the past 105 days) with T2DM diagnosis. Concomitant use with a DPP-4 agent requires clinical review. Policy directs to 'PDL category Anti-obesity Select Agents for a list of covered agents' for weight management use.

Policy effective March 1, 2026 · verified June 4, 2026 · source: Ms Medicaid Pdl March 2026 V1 Updated 02 26 2026 · View policy document (PDF)

Open on its own page →

Questions people ask
Does Mississippi Medicaid cover Mounjaro?
Yes. Mississippi Medicaid covers Mounjaro for type 2 diabetes with prior authorization. Other policy requirements and your plan's benefits also apply.
How current is this information?
The oldest review date among the policies on this page is June 4, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Card and program names on file in Mississippi

These names map to Mississippi Medicaid, including older names and spelling variants. This is not a list of plans currently accepting members.

Also under Mississippi Medicaid: Ozempic, Wegovy

Mounjaro under other plans: BCBS Mississippi, Alabama Medicaid, Arkansas Medicaid, California Medicaid, Colorado Medicaid, Connecticut Medicaid, Delaware Medicaid, Florida Medicaid

All insurance plans · All medications

Summary of Mississippi Medicaid's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.